Evidence map›Paper›PMID 39485602›Full record

ArticleCardiology and therapy2024

Sodium Zirconium Cyclosilicate for Renin-Angiotensin-Aldosterone System Inhibitor Optimization in Patients with Heart Failure with Reduced Ejection Fraction: A Retrospective Analysis.

Rhys Williams, William Ford, Alexander James, Kerys Thomas, Aaron Wong

Abstract read
In one paragraph

Article in Cardiology and therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rhys WilliamsCardiology Department, Princess of Wales Hospital, Bridgend, UK.
William Ford *Welsh School of Pharmacy and Pharmaceutical Sciences, Cardiff, UK.
Alexander James *Cardiology Department, Princess of Wales Hospital, Bridgend, UK.
Kerys ThomasCardiology Department, Gorseinon Hospital, Swansea, UK.
Aaron WongCardiology Department, Princess of Wales Hospital, Bridgend, UK. Aaron.Wong@wales.nhs.uk.ORCID http://orcid.org/0000-0002-4701-7227

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn this retrospective analysis, we evaluate the effectiveness of the potassium (K

methodsA total of 44 patients with HFrEF and a history of hyperkalemia who were receiving SZC to enable the prescription of RAASi were identified from two district general hospital sites. Retrospective analysis was performed to determine biochemical response, alterations in pharmacotherapy, and subsequent HF outcomes following initiation of SZC.

resultsMean K

conclusionsExtended real-world treatment with the K

Indexed as

Heart failureHyperkalemiaRenin–angiotensin–aldosterone system inhibitorSodium zirconium cyclosilicate

Identifiers

PMID39485602
PMCPMC11607300

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.